Cystourethroscopes

Welcome to Cystourethroscopes Site
Cystourethroscopes Resources

Home > Cystourethroscopes > Medtech Startups, January 2008

Medtech Startups, January 2008




New medical technologies represented in companies added (January 2008) to the Medtech Startups Database and/or added to the January 2008 issue of MedMarkets.

The following are brief technology descriptions for companies newly added to the MedMarket Diligence Medtech Startups Database and/or covered in MedMarkets Startups during the month of December:

  • Treatment of neurological and psychiatric disorders by, for example, electrical stimulation.
  • Developing technologies to visualize vascular junctions in order to enhance ablation in treatment of atrial fibrillation.
  • Technologies for embolic cerebral protection to reduce embolic stroke during interventional procedures.
  • Ophthalmic technologies targeting vision loss.
  • Developing a device for retro-muscular mesh placement in hernia repair.
  • Femoral head resurfacing implant with internal fixation and instrumentation.
  • Materials to enhance in situ tissue regeneration.
  • Integrated insulin pump and glucose monitor for insulin-dependent diabetes.
  • MRI-guided robotic breast cancer intervention.
  • Nanoparticle-based delivery of chemotherapeutic agents for cancer.
  • Ophthalmic device technologies.
  • Device technologies to enhance left ventricular assist device (LVAD) implantation.
  • Motion preserving spine fusion implant, inserted minimally invasively, for treatment of degenerative disc disease.
  • Device technology to reduce incisions in laparoscopic surgery.

Now Published!: Worldwide Wound Management 2007-2016. see link

For coverage in specific issues of MedMarkets, see link.

For details on the Medtech Startups Database, see link.

Tags: medtech, startup


Click Here to read the entire article...




Other Articles:


Aradigm Reports Successful Top-Line Phase 2 Data With Inhaled Liposomal Ciprofloxacin For Cystic Fibrosis
Aradigm Corporation (OTCBB:ARDM) (the "Company") announced positive results from an open-label, two week efficacy and safety study of its once daily inhaled liposomal ciprofloxacin in patients with cystic fibrosis (CF). The study conducted at leading CF centers in Australia and New Zealand enrolled a total of 22 patients.
Click Here to read the entire article...
Listen to The Lancet: 31 May
In this week's podcast, editor Sally Hargreaves talks to the author of a Research Article published early online on sudden unexplained death in infants (SUDI). Although sudden infant death remains one of the most common presentations of post-neonatal infant death in the UK, there still remain numerous theories about its cause. Dr Neil Sebire from the Great Ormond Street Hospital for Children, London, UK, discusses with Sally key findings and implications of the study. Researchers found high levels of Staphylococcus aureus and Escherichia coli bacteria in post-mortem samples from unexplained cases of SUDI, suggesting that these bacteria could be associated with the condition.
Click Here to read the entire article...
Fireworks
none
Click Here to read the entire article...
zoom rythmtrak rt 123 drum machine
£20.00 (0 Bid)
End Date: Thursday Aug-07-2008 19:01:43 BST
Buy It Now for only: £45.00
Bid now | Buy it now | Add to watch list
Click Here to read the entire article...
Assisted Fertilization Risks May Be Due to Infertility (HealthDay)
HealthDay - THURSDAY, July 31 (HealthDay News) -- The increased risk of poor health outcomes among single infants conceived through assisted fertilization (AF) may be due to causes of infertility rather than the procedure itself, say Norwegian researchers.
Click Here to read the entire article...
[Medical_Sciences] Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice

Brain arteriovenous malformations (BAVMs) can cause devastating stroke in young people and contribute to half of all hemorrhagic stroke in...

Click Here to read the entire article...
New Medical Technology Companies, from MedMarket Diligence, LLC
By info@mediligence.com - Copyright 2006, MedMarket Diligence, LLC - version: v1.5 build A